FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1583794602> ?p ?o ?g. }

• W1583794602 endingPage "35" @default.
• W1583794602 startingPage "1027" @default.
• W1583794602 abstract "We have investigated the role played by cyclic nucleotide phosphodiesterases (EC 3.1.4.17) in the control of T-lymphocyte response to mitogenic agents by their ability to influence the cellular level of cAMP. The importance of this messenger as a negative regulator in this cell type is well established. Multiple isoenzymes of phosphodiesterase were fractionated from the cytosol of rat thymic lymphocytes by high performance liquid chromatography on an anion exchange column. In addition to the type II, III, IV isoforms that we have already described [Valette et al., Biochem. Biophys. Res. Commun. 169:864-872 (1990)], a phosphodiesterase fraction sharing several of the characteristics of type V, cGMP-binding phosphodiesterase, was detected. Non-isoform-selective inhibitors of phosphodiesterase such as dipyridamole, papaverine, and methyl-isobutylxanthine were able to totally prevent the proliferative response of thymocytes to stimulation by the mitogenic lectin concanavalin A. In contrast, the selective inhibitor of type IV phosphodiesterases rolipram induced a rather moderate inhibition of proliferation, not exceeding 60%; and the selective inhibitors of type III and type V phosphodiesterases, milrinone and M&B 22,948, respectively, displayed only marginal inhibitory effects. The association of the type III and IV phosphodiesterase inhibitors produced synergistic inhibition of proliferation, which could then be almost totally suppressed. These inhibitory effects on cell multiplication were reflected at the level of the cell cAMP content; only rolipram was able to induce a significant (approximately 50%) increase in cAMP, and this increase was potentiated by the presence of milrinone, reaching almost 100%. The type V phosphodiesterase selective inhibitor M&B 22,948 displayed similar properties to those of milrinone, which suggests that it indirectly inhibited the type III, cGMP-inhibitable isoenzyme, by inducing a cGMP rise. This hypothesis was supported by evidence of a significant raising effect of M&B 22,948 on cGMP level, and by the ability of a cGMP-elevating agent, sodium nitroprusside, to mimic the synergistic effects of milrinone associated with rolipram. Furthermore, 8-bromo-cGMP, a potent activator of cGMP-dependent protein kinase, which showed only weak inhibitory effects on thymic type III phosphodiesterase, failed to alter the effects of rolipram on the cell proliferation. These results allow us to delineate a role for types III, IV, and V phosphodiesterase in the control of cAMP level during the proliferative response of thymic lymphocytes. They also suggest that endogenously formed cGMP might participate in the regulation of cAMP level in the cells by means of the inhibition of the type III phosphodiesterase.(ABSTRACT TRUNCATED AT 400 WORDS)" @default.
• W1583794602 created "2016-06-24" @default.
• W1583794602 creator A5002894950 @default.
• W1583794602 creator A5039757644 @default.
• W1583794602 creator A5069370240 @default.
• W1583794602 creator A5073572553 @default.
• W1583794602 date "1993-11-01" @default.
• W1583794602 modified "2023-10-06" @default.
• W1583794602 title "Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents." @default.
• W1583794602 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8246905" @default.
• W1583794602 hasPublicationYear "1993" @default.
• W1583794602 type Work @default.
• W1583794602 sameAs 1583794602 @default.
• W1583794602 citedByCount "9" @default.
• W1583794602 crossrefType "journal-article" @default.
• W1583794602 hasAuthorship W1583794602A5002894950 @default.
• W1583794602 hasAuthorship W1583794602A5039757644 @default.
• W1583794602 hasAuthorship W1583794602A5069370240 @default.
• W1583794602 hasAuthorship W1583794602A5073572553 @default.
• W1583794602 hasConcept C104317684 @default.
• W1583794602 hasConcept C134018914 @default.
• W1583794602 hasConcept C153911025 @default.
• W1583794602 hasConcept C155710745 @default.
• W1583794602 hasConcept C163235415 @default.
• W1583794602 hasConcept C170493617 @default.
• W1583794602 hasConcept C181199279 @default.
• W1583794602 hasConcept C185592680 @default.
• W1583794602 hasConcept C19869320 @default.
• W1583794602 hasConcept C202751555 @default.
• W1583794602 hasConcept C2776645727 @default.
• W1583794602 hasConcept C2776846068 @default.
• W1583794602 hasConcept C2776958096 @default.
• W1583794602 hasConcept C2778524494 @default.
• W1583794602 hasConcept C2779276759 @default.
• W1583794602 hasConcept C2780215583 @default.
• W1583794602 hasConcept C2781298581 @default.
• W1583794602 hasConcept C512185932 @default.
• W1583794602 hasConcept C55493867 @default.
• W1583794602 hasConcept C58141971 @default.
• W1583794602 hasConcept C62826618 @default.
• W1583794602 hasConcept C79418042 @default.
• W1583794602 hasConcept C86803240 @default.
• W1583794602 hasConceptScore W1583794602C104317684 @default.
• W1583794602 hasConceptScore W1583794602C134018914 @default.
• W1583794602 hasConceptScore W1583794602C153911025 @default.
• W1583794602 hasConceptScore W1583794602C155710745 @default.
• W1583794602 hasConceptScore W1583794602C163235415 @default.
• W1583794602 hasConceptScore W1583794602C170493617 @default.
• W1583794602 hasConceptScore W1583794602C181199279 @default.
• W1583794602 hasConceptScore W1583794602C185592680 @default.
• W1583794602 hasConceptScore W1583794602C19869320 @default.
• W1583794602 hasConceptScore W1583794602C202751555 @default.
• W1583794602 hasConceptScore W1583794602C2776645727 @default.
• W1583794602 hasConceptScore W1583794602C2776846068 @default.
• W1583794602 hasConceptScore W1583794602C2776958096 @default.
• W1583794602 hasConceptScore W1583794602C2778524494 @default.
• W1583794602 hasConceptScore W1583794602C2779276759 @default.
• W1583794602 hasConceptScore W1583794602C2780215583 @default.
• W1583794602 hasConceptScore W1583794602C2781298581 @default.
• W1583794602 hasConceptScore W1583794602C512185932 @default.
• W1583794602 hasConceptScore W1583794602C55493867 @default.
• W1583794602 hasConceptScore W1583794602C58141971 @default.
• W1583794602 hasConceptScore W1583794602C62826618 @default.
• W1583794602 hasConceptScore W1583794602C79418042 @default.
• W1583794602 hasConceptScore W1583794602C86803240 @default.
• W1583794602 hasIssue "5" @default.
• W1583794602 hasLocation W15837946021 @default.
• W1583794602 hasOpenAccess W1583794602 @default.
• W1583794602 hasPrimaryLocation W15837946021 @default.
• W1583794602 hasRelatedWork W1583794602 @default.
• W1583794602 hasRelatedWork W1959582949 @default.
• W1583794602 hasRelatedWork W1988408001 @default.
• W1583794602 hasRelatedWork W2025207475 @default.
• W1583794602 hasRelatedWork W2082825637 @default.
• W1583794602 hasRelatedWork W2083980443 @default.
• W1583794602 hasRelatedWork W2089352351 @default.
• W1583794602 hasRelatedWork W2273766011 @default.
• W1583794602 hasRelatedWork W2399819413 @default.
• W1583794602 hasRelatedWork W2471636327 @default.
• W1583794602 hasVolume "44" @default.
• W1583794602 isParatext "false" @default.
• W1583794602 isRetracted "false" @default.
• W1583794602 magId "1583794602" @default.
• W1583794602 workType "article" @default.